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The VAB-1 Eph Receptor Tyrosine Kinase
Functions in Neural and Epithelial
Morphogenesis in C. elegans
gastrulation (fog) (Costa et al., 1994). Thus, both these
types of epithelial morphogenesis involve cell signaling,
either via JNK and TGFb pathways in epiboly or via cta
and fog pathways in invagination.
The epidermis of the nematode Caenorhabditis ele-
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gans is a simple system in which to analyze epithelialSanta Cruz, California 95064
morphogenesis. The epidermis, also known as hypoder-²Program in Cellular and Molecular Biology
mis, begins as a set of cells born in the dorsal part of³Department of Zoology
the embryo (Sulston et al., 1983) that forms an epithelialUniversity of Wisconsin
sheet. Ventral enclosure of the embryo by the epidermisMadison, Wisconsin 53706
occurs in two steps (Williams-Masson et al., 1997). Four
anterior epidermal cells lead the migration of the epider-
mis to the ventral midline by extending actin-rich filo-Summary
podia over substrate neurons. Once these leading cells
have reached the midline, the remainder of the ventralMutations in the C. elegans vab-1 gene disrupt the
midline appears to be enclosed by an actin-mediatedcoordinated movements of cells during two periods
purse-string mechanism. After enclosure is complete,of embryogenesis. vab-1 mutants are defective in the
circumferential constriction in the epidermis squeezesmovement of neuroblasts during closure of the ventral
the embryo longitudinally (Priess and Hirsh, 1986).gastrulation cleft and in the movements of epidermal
To identify genes involved in epidermal morphogene-cells during ventral enclosure of the embryo by the
sis, we have analyzed mutants in which morphogenesisepidermis. We show that vab-1 encodes a receptor
is defective. vab-1 mutants were originally isolated bytyrosine kinase of the Eph family. Disruption of the
Brenner (1974) based on their morphogenetic defectskinase domain of VAB-1 causes weak mutant pheno-
in head epidermis. Here, we show that vab-1 is alsotypes, indicating that VAB-1 may have both kinase-
required for cell movements following gastrulation anddependent and kinase-independent activities. VAB-1
during ventral closure of the epidermis. We show thatis expressed in neurons during epidermal enclosure
vab-1 encodes an Eph receptor expressed in neuro-and is required in these cells for normal epidermal
blasts and neuronal cells and that vab-1 function in thesemorphogenesis, demonstrating that cell±cell interac-
neuronal cells is required for epidermal morphogenesis.tions are required between neurons and epidermal
Our results provide an example of interactions betweencells for epidermal morphogenesis.
neuronal substrate cells and a migrating epithelial sheet
in morphogenesis.Introduction
ResultsThe shape of an organism is determined by the morpho-
genetic behavior of its cells. While we know much about
vab-1 Mutants are Defective in Morphogenesis
the process of morphogenesis at the descriptive level
The most striking defect of vab-1 mutant larvae is the
and from experimental embryology and biochemistry,
deformation of head epidermis, the ªNotched headº
relatively little is known of the genetic mechanisms un-
phenotype (Brenner, 1974; Figures 1A and 1B); epider-
derlying morphogenetic movements (Bard, 1992). Many
mal morphogenesis is often also abnormal in the tail
common types of morphogenetic movements involve
region (Figure 1B). Morphology of the body is normal in
epithelia, such as invagination and spreading (epiboly).
most vab-1 mutants. The phenotypes caused by vab-1
One approach to understanding the molecular mecha-
alleles are incompletely penetrant and variably ex-
nisms underlying such movements is to use genetic
pressed, hence the gene name vab (variable abnormal).
analysis to identify mutants defective in such move-
The number of head epidermal cells and nuclei is normal
ments. Genetic analysis in Drosophila melanogaster has
in Notched head vab-1 mutants, as determined by No-
identified cell signaling pathways required for dorsal marski microscopy and expression of epidermal mark-
epidermal closure (Knust, 1997), including a JNK path- ers (data not shown), indicating that the Notched head
way that regulates cell shape changes in the leading phenotype results specifically from abnormal morpho-
edge (Glise et al., 1995; Riesgo-Escovar et al., 1996; genesis of head epidermal syncytia (Figures 1C and 1D).
Sluss et al., 1996), and TGFb signaling pathways that Seventeen recessive zygotic vab-1 mutant alleles
may transmit signals to cells behind the leading edge. have been isolated by various workers (see Experimen-
Another type of epithelial morphogenesis that has tal Procedures). We classified vab-1 alleles as strong,
been analyzed genetically is ventral furrow invagination intermediate, or weak, based on the penetrance of mu-
during Drosophila gastrulation. Genetic screens have tant phenotypes (Table 1); most animals mutant for
identified two loci required for cell shape changes in strong vab-1 alleles arrest during embryogenesis due
gastrulation: the Ga subunit concertina (cta) (Parks and to defects in epidermal enclosure (see below), whereas
Wieschaus, 1991) and the novel secreted protein folded weak vab-1 mutants are almost fully viable. By genetic
and molecular criteria (Tables 1 and 2), the strong vab-1
alleles cause complete loss of function.§To whom correspondence should be addressed.
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Figure 1. Morphogenetic Phenotypes of vab-1
Mutant Larvae
(A) Wild-type first stage (L1) larva. Anterior is
to the left, and dorsal is up. Bar, 20 mm.
(B) Abnormal Notched head and abnormal tail
morphogenesis of vab-1(e2027) L1 larva.
(C) Wild-type L1 larva stained with the MH27
monoclonal antibody to show junctions be-
tween epidermal cells; the head epidermal
syncytia hyp5 (h5), hyp6, and hyp7 are
marked.
(D) vab-1(dx14) mutant L1 larva, MH27 stain-
ing, showing malformation of hyp5, hyp6, and
hyp7 cells.
vab-1 Null Mutations Cause Variable Defects The variable phenotypes of vab-1 null mutants can be
described in terms of five phenotypic classes (Figure 2in Cell Movements following Gastrulation
and during Embryonic Ventral legend).
Approximately 35% of vab-1 null mutant animals dis-Enclosure of the Epidermis
To determine the role of vab-1 in embryonic develop- played defects in cell movements following gastrulation.
During normal C. elegans gastrulation, a ventral cleft isment of the epidermis, we analyzed the embryogenesis
of vab-1 mutant embryos using conventional and four- formed by the movement of endoderm, mesoderm, and
germline precursors into the interior of the embryo; thisdimensional Nomarski microscopy. We found that vab-1
null mutant embryos are variably defective in the move- cleft is gradually closed by the short-range lateral move-
ments of many neuroblasts (Figures 2A and 2C) (Sulstonments of neuroblast cells during closure of the ventral
gastrulation cleft and in the migrations of epidermalcells et al., 1983). In 20% of vab-1 embryos (phenotypic
classes I and II), the ventral cleft is deeper than normalduring ventral enclosure of the epidermis. These defects
in cell movements result in failure of enclosure of the and remains for longer (Figure 2E); in 15% of embryos
the cleft is of normal depth and lasts longer (class III).embryo by epidermal cells, and such embryos arrest
because internal cells leak out at the ventral midline. These phenotypes appear to result from delays in the
Table 1. Strength of vab-1 Mutations and Molecular Lesions
Embryonic Adult, Wild-Type Predicted
Allele Arrest Larval Arrest Adult, Vab Non-Vab Sequence Mutant Sequence Effect
Strong
e2027 58.2% 31.3% 8.9% 2.5% Ð 74 bp deletion removing
first 7 bp of exon 5
e721 58.2% 29.3% 11.4% 1.0% ND ND
dx14 56.1% 29.6% 9.5% 4.7% Ð deletion of exon 4,
part of exon 5
ju8 53.3% 32.5% 13.2% 0.8% CAA AAA E62K
dx31 50.8% 33.2% 14.0% 2.0% deletion of exons 1±4
e1059 49.9% 36.0% 12.5% 1.4% CAG TAG Q21amber
Intermediate
tn2 30.3% 14.9% 33.4% 21.3% TGG TAG W932amber
e856 19.9% 26.7% 45.0% 8.4% GAG AAG E195K
e699 9.0% 20.9% 51.2% 19.8% ACT ATT T63I
Weak
e118 10.1% 8.6% 45.6% 35.8% Ð 326 bp deletion in exon 10
e2 10.2% 5.5% 31.4% 51.4% GGA GAA G917E
ju63 9.2% 7.0% 52.1% 31.5% CAG TAG W964amber
ju22 8.5% 6.4% 53.8% 31.2% TGT TTT C966F
e1063 8.3% 6.6% 51.0% 34.0% TGT TAT C966Y
e116 6.4% 17.5% 50.7% 25.3% TGG TGA W921opal
e200 5.6% 3.1% 44.4% 46.7% tttcag|AAG tttcaa|AAG exon 2
splice
acceptor
e1029 5.9% 1.9% 45.7% 46.5% ND ND
Mutant phenotypes were quantitated as described in Experimental Procedures. We classify vab-1 mutations as strong (.50% lethality),
intermediate (25%±50% lethality), or weak (,25% lethality). Most larval arrest animals arrested during L1 or L2 stages; some vab-1 larvae
rupture at the rectum. Some (,5%) adult animals showed egg-laying defects. Wild-type and mutant vab-1 genomic DNA sequences are
shown with the predicted effects on VAB-1 protein.
ND, not determined.
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Table 2. The vab-1 Null Phenotype Is a Variable Defect in Morphogenesis
Arrest at or Arrest Later Hatched, Abnormal Hatched, Normal
Parental Genotype (n) before 2-Fold Than 2-Fold Head or Tail Head and Tail
vab-1(133) 18.0% (24) 23.3% (31) 58.6% (78) 0% (0)
vab-1/1 (152) 8.5% (13) 7.8% (12) 11.2% (17) 72% (110)
vab-1/1 3 ccDf4/1 (81) 8.6% (7) 5% (4) 11.1% (9) 75.3% (61)
ccDf4/1 3 maDf4/1 (105) 12.3% (13) 7.6% (8) 3.8% (4) 76.2% (80)
Arrest stages of vab-1 mutants were scored as described in Experimental Procedures. Arrest at or before 2-fold stages corresponds to
phenotypic Classes I-III and some Class IV phenotypes, arrest later than 2-fold corresponds to a subset of Class IV phenotypes, embryos
that hatch correspond to Class V. Data for the strong vab-1 allele e2027 are shown; similar results were obtained for other strong vab-1
alleles. Similar ranges of phenotypes are seen in progeny from homozygous vab-1(e2027) mothers and in one quarter of the progeny of vab-
1(e2027)/1 mothers, indicating that there is no maternal effect for vab-1. The range of phenotypes of vab-1(e2027), vab-1(e2027)/Df, and Df/
Df animals are similar, consistent with vab-1(e2027) being a null mutation.
lateral movements of the neuroblasts that normallyclose of hlh-1, tested genomic DNA clones from this region
(Figure 3A) for their ability to rescue Vab-1 phenotypesthe gastrulation cleft. Thus, vab-1 function is required
for neuroblast movements following gastrulation. in transgenic lines, and found that the cosmid M03A1
fully rescued vab-1(e2027) mutant phenotypes. Geno-Approximately 35% of vab-1 null mutant embryos dis-
played severe defects in cell movements during the pro- mic sequence available from the C. elegans genome
consortium predicted a gene from this cosmid that couldcess of epidermal enclosure. During ventral enclosure
of the epidermis in wild-type embryos, leading cells of encode a receptor protein-tyrosine kinase (RPTK) of the
Eph subfamily. This RPTK gene is mutated in vab-1the epidermis migrate over neurons, from lateral posi-
tions to theventral midline (Figures 2B and 2D) (Williams- mutants (see below), establishing that this gene is vab-1.
vab-1 produces a 4 kb transcript expressed throughoutMasson et al., 1997). The epidermal leading edge cells
fail to migrate or migrate more slowly than normal in development (data not shown). We determined the
cDNA sequence corresponding to this vab-1 transcriptvab-1 animals (phenotypic class I: Figure 2F), or they
migrate to the ventral midline and fail to form junctions as described in Experimental Procedures.
The predicted VAB-1 protein (Figure 4A) is most simi-correctly (class II). The leading cells in class I and II
embryos often send actin-rich processes to abnormally lar to Eph-related RPTKs, recently renamed Eph recep-
tors (Eph Nomenclature Committee, 1997). The Eph re-anterior regions, as determined by phalloidin staining
(data not shown), and migrate to abnormally anterior ceptor subfamily is the largest subfamily of RPTKs (Orioli
and Klein, 1997). EphA receptors bind GPI-linked ephrinpositions (Figure 2F). As a result, ventral closure is in-
complete, and internal cells ooze through a hole in the ligands, and EphB receptors bind transmembrane ephrins
(Gale et al., 1996); VAB-1 shows equal sequence similar-ventral midline of the epidermis when elongation begins,
resulting in rupture and arrest of the embryo. In other ity to EphA and EphB subclasses. VAB-1 contains all
hallmark features of Eph receptors (Figures 3B and 3C),embryos (class III) the leading cells meet up normally,
but internal cells ooze from the region of the posterior including in its extracellular domain an N-terminal globu-
lar domain with weak similarity to immunoglobulin do-leading cells after elongation (Figure 2I), suggesting that
the cells do not properly connect with their partners. In mains (O'Bryan et al., 1991), a cysteine rich domain, in
which the positions of the cysteine residues are highly65% of vab-1 embryos, closure of the gastrulation cleft
appears normal, and the embryos elongate to the conserved among Eph family members, and two fibro-
nectin type III repeats. The intracellular domain of VAB-11.5-fold or 2-fold stage (classes IV and V); about one-
third of these embryos rupture along the ventral midline contains the juxtamembrane motif Y(I/V)DPXTYEDP found
in all vertebrate Eph receptors and a tyrosine kinaseat the 2-fold stage or later (Figure 2J), indicating a late
defect in ventral enclosure; and the remaining two-thirds catalytic domain most similar (59% identical) to that of
human EphA3/Hek and between 51% and 58% identicaldo not rupture (class V; data not shown). The phenotype
of class IV embryos, in which closure of the ventral to those of other Eph receptors (Figure 3E). Unlike other
Eph receptor kinase domains, the VAB-1 kinase domaingastrulation cleft is normal but epidermal enclosure is
defective, suggests that the ventral enclosure defects contains an insert sequence (A719-E743) between sub-
domains I and II.in vab-1 embryos are not merely a consequence of the
defects in ventral cleft closure.
In vab-1 embryos, internal organs and tissues differ- Mutations in the VAB-1 Extracellular Domain
entiate normally, as judged by Nomarski microscopy. Cause Strong or Intermediate
Several markers of neuronal and epidermal cell fates Mutant Phenotypes
were examined and showed normal expression in vab-1 To identify functionally important parts of the VAB-1
mutants (data not shown). Thus, the morphogenetic de- protein, we determined the molecular lesions of vab-1
fects in vab-1 embryos do not appear to be due to mutant DNAs (Table 1). Several of the strong alleles had
improper specification of neural or epidermal fates. lesions consistent with their genetic behavior as null
mutations. Three strong alleles, dx14, dx31, and e2027,
cause deletions of sequences encoding parts of thevab-1 Encodes an Eph Receptor
Protein-Tyrosine Kinase extracellular domain (Figure 3A), and e1059 is an amber
stop in thesignal peptide. One strong and two intermedi-We cloned vab-1 using genetic mapping and transfor-
mation rescue. We mapped vab-1 close to the right ate alleles causemissense alterationsin theextracellular
Cell
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Figure 2. Cell Movement Defects following
Gastrulation and during Ventral Closure in
vab-1 Embryos
In wild-type embryos the gastrulation cleft (A
and C) is normally 1±2 mm deep and closes
230±290 min postfertilization; epidermal en-
closure (B and D) occurs between 310±340
min. (C±F), ventral Nomarski views, anterior
to left. Bar, 15 mm. (G±H), lateral views.
vab-1 class I phenotype (z14% of animals):
embryo is rounded, double ventral gastrula-
tion cleft forms single cleft (arrow in [E]) 4±5
mm deep that persists throughout enclosure.
Ventral closure fails early (F): leading cells
(arrow) fail to migrate or migrate slowly. In
class I embryos the ventral pocket attempts
to form, and the embryos display muscular
twitching. The class II phenotype (z5% of
animals, data not shown) is similar, only
weaker. (G and H) Wild-type comma stage
and 2-fold stage embryos. Animalsdisplaying
a class III phenotype (z15% of animals) show
a transient 1±2 mm deep cleft, similar to wild-
type but persisting approximately 30 min
longer. The leading edge cells zip up nor-
mally, and the ventral pocket forms. The em-
bryo oozes from the region of the posterior
leading edge after elongation begins (arrow,
[I]). Class IV animals (z23% of animals) ini-
tially appear normal and elongate to the 1.5-
fold or 2-fold stage, then ooze along the ven-
tral midline in the head or tail (arrow, [J]).
Class V embryos (z43% of animals; data not
shown) show no embryonic abnormality and
hatch. Some class III, IV, and V embryos have
enlarged buccal cavities and develop a
Notched head.
domain and might define functionally important residues alleles e2, e1063, and ju22 cause missense alterations
of conserved residues that function to stabilize thein Eph receptors. The strong allele ju8 and the intermedi-
ate allele e699 affect residues (E62K and T63I, respec- structure of other kinase domains (Hubbard et al., 1994).
Three weak alleles should truncate the kinase domain:tively) in the N-terminal globular domain, and the e856
mutation affects the cysteine-rich domain (Figure 3D); ju63 and e116 cause stop codons, and e118 is a deletion
of the C-terminal 202 residues of VAB-1. One allele, tn2,these domains have been implicated in ephrin±Eph re-
ceptor interactions (Labrador et al., 1997). causes a stop codon in kinase subdomain IX yet causes
an intermediate mutant phenotype; it is unclear why the
tn2 phenotype is stronger than those of the other kinaseMutations in the VAB-1 Kinase Domain
domain alleles. The above mutations would be predictedCause Weak Mutant Phenotypes
to abolish catalytic activity of VAB-1, yet none appearsSeven vab-1 mutations disrupt the kinase domain of
to cause complete loss of vab-1 function, suggestingVAB-1 (Figure 3E) and are likely to cause severe loss of
that VAB-1 may possess both kinase-dependent andkinase activity (see Discussion). Strikingly, six of these
seven alleles cause weak mutant phenotypes. The weak kinase-independent functions.
Eph Receptor in C. elegans Morphogenesis
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vab-1 Reporter Constructs Are Widely Expressed
in Early Embryos but Only in Nonepidermal
Cells during Ventral Enclosure
To determine the pattern of expression of vab-1, we
used reporter constructs containing translational fu-
sions of the vab-1 locus to green fluorescent protein
(GFP; see Experimental Procedures). Such vab-1::GFP
constructs fully rescued vab-1(e2027) mutant pheno-
types, indicating that these constructs reflect theendog-
enous vab-1 expression pattern. Expression from one
such construct, juIs24, was analyzed in detail.
VAB-1::GFP was expressed in many cells during late
gastrulation; based on their positions these cells include
the neuroblasts whose movement is defective in vab-1
mutants (Figure 4A) and may also include some epider-
mal precursors. During ventral enclosure of the epi-
dermis, VAB-1::GFP was expressed in clusters of cells
of the head and tail regions (Figures 4B±4F). In the
head region, VAB-1::GFP was expressed in clusters of
presumptive neuronal cells. Early in enclosure these
cells appear to lie beneath the epidermal leading cells
(Figures 4C and 4D); later in enclosure, the VAB-1±
expressing cells lie anterior to the leading cells (Figure
4E). VAB-1::GFP was not detectably expressed in the
epidermal leading cells at any stage during ventral en-
closure. In the posterior of the embryo, VAB-1::GFP was
expressed in several cells, including QV5 and the ventral
hyp7 cells posterior to the rectum (data not shown);
VAB-1::GFP was also expressed in several pharyngeal
cells (Figure 4G). In late embryogenesis and throughout
larval and adult development, VAB-1::GFP was localized
to the axons of many neurons throughout the nervous
Figure 3. Molecular Cloning and Sequence Analysis of vab-1 system (Figures 4G and 4H). Thus, in most stages follow-
(A) Genetic and physical maps of the vab-1 region and structure of ing gastrulation, VAB-1::GFP is widely expressed in the
the vab-1 transcription unit. Genetic mapping placed vab-1 0.07
developing nervous system. Expression of VAB-1::GFPmap units to the right of hlh-1. Cosmid clones were mapped by the
in the larval nervous system suggested that vab-1 mightC. elegans genome project. B0304 contains hlh-1; M03A1 contains
function in neural development; although vab-1 mutantsvab-1. The position of the intron between exons 2 and 3 is conserved
between vab-1 and chicken EphB2 (Connor and Pasquale, 1995), do not display obvious behavioral defects, we have
and the position of the intron between exons 6 and 7 is conserved found that vab-1 mutants display defects in axonal out-
between vab-1, chicken EphB2, and rat EphA5 (Maisonpierre et al., growth and fasciculation (S. E. G. and A. D. C., unpub-
1993), suggesting that these genes might share a common ancestor.
lished data).Locations of the deletions dx14, dx31, e2027, e118, and the splice
site mutation e200 are shown.
vab-1 Function Is Required in Nonepidermal(B) Sequence of the predicted VAB-1 protein. The signal sequence
(residues 1-28) and transmembrane domain (residues 559-581) are Cells for Epidermal Morphogenesis
italicized. Potential N-linked glycosylation sites (NX[T/S]) are under- The expression of VAB-1::GFP reporter constructs in
lined. The conserved cysteines in the cysteine-rich domain are in nonepidermal cells during epidermal enclosure led us
boldface and shaded.
to ask whether the epidermal morphogenetic defects in(C) Domains of VAB-1 and locations of point mutations. SS, signal
vab-1 mutants are due to a requirement for vab-1 func-sequence; TM, transmembrane domain.
tion in neurons. We used genetic mosaic analysis(D) Alignment of the VAB-1 N-terminal globular domain and part of
the cysteine-rich-domain with those of the closest vertebrate EphA (Herman, 1995) to determine in which cells vab-1 is nec-
and EphB receptors. The VAB-1 extracellular domain (residues 55- essary for normal morphogenesis. Because genetic mo-
550) is most similar (27% identity, 42% similarity) to chicken EphB2/ saics could not be identified during embryogenesis, we
Cek5 (Pasquale, 1991); within the EphA subfamily the extracellular
analyzed viable vab-1 genetic mosaics. We identifieddomain of human EphA4/Hek8 (Fox et al., 1995) is most similar to
83 vab-1 genetic mosaics, 56 of which displayed mor-VAB-1 (27% identity, 41% similarity). Sequences were aligned using
phogenetic defects in head epidermis (the Vab pheno-ClustalW; identities are in black and conserved residues in gray.
ju8, which changes a glutamate to a lysine (charge reversal), and type). All such Vab mosaics proved to have lost vab-1
the intermediate allele e699, which changes a polar residue (threo- within the AB lineage, which generates head epidermal
nine) to a nonpolar residue (isoleucine) affect a poorly conserved
part of the N-terminal globular domain. The intermediate allele e856
changes a glutamate to a lysine; the equivalent residue is aspartate
(negatively charged) in most vertebrate Eph receptors. 991) is most similar (59% identity, 72% similarity) to that of human
(E) Alignment of VAB-1 kinase subdomains IX-XI with the most simi- EphA3/Hek (Wicks et al., 1992); the EphB with highest similarity to
lar vertebrate EphA and EphB kinase domains and location of vab-1 VAB-1 in the kinase domain is chicken EphB2/Cek5 (58% identity,
kinase domain mutations. The VAB-1 kinase domain (residues 665- 72% similarity).
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Figure 4. Expression Pattern of vab-1 Reporter Constructs
Confocal images of VAB-1::GFP expression from the juIs24 transgene (visualized using anti-GFP antibodies [green]) and epidermal cell junctions
(MH27 antigen [red]).Bars, 15 mm. (A) VAB-1::GFP expression in postgastrulation embryo (z200±250 min).Ventral view. Not allVAB-1±expressing
cells have been identified at this stage; based on position most of the cells are neuroblasts. Some epidermal precursors may also express
VAB-1::GFP. (B and C) Beginning of ventral closure, ventrolateral and ventral views (D). Later in ventral closure, leading epidermal cells are
marked (arrows). (E) Midventral closure; leading cells have met at ventral midline, ventral view; ventral pocket has not yet closed. (F) Completed
ventral enclosure (comma stage). (G) L1 larval animal showing expression of VAB-1::GFP ( juIs33 transgene) in the nervous system; nerve ring
and ventral nerve cord are arrowed. Strong expression is also seen in the procorpus and terminal bulb of the pharynx. (H) Expression of VAB-
1::GFP in axons in late larval animal; lateral view, close-up of expression in D neuron axon commissure (arrowed) and ventral cord.
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tyrosine kinase. The phenotypes of null and kinase do-
main mutations in VAB-1 suggest that the VAB-1 RTK
has both kinase-dependent and kinase-independent
functions. Our analysis of vab-1 mutant phenotypes,
expression pattern, and genetic mosaics suggests that
vab-1 functions in neuronal cells to regulate normal mor-
phogenesis of the epidermis.
Evolutionary Conservation of Eph Signaling Pathways
VAB-1 is most similar to receptor tyrosine kinases of
the Eph subfamily.Eph receptors were first isolated from
vertebrates by homology in the kinase domain (Hirai et
al., 1987) and are the largest subfamily of RPTK (Orioli
and Klein, 1997). Previously, Eph receptors have only
been reported from vertebrates. Our findings show that
the Eph receptor family is ancient and likely to be con-
served among all animals.
Eph receptors bind membrane-bound protein ligands,
recently renamed ephrins (Eph Nomenclature Commit-
tee, 1997). Ephrins are either membrane-anchored in
cell membranes via glycosylphosphatidylinositol (GPI)
Figure 5. Mosaic Analysis of vab-1 anchors (ephrin-As) or are integral membrane proteins
(A) Partial lineage of C. elegans showing points at which arrays were (ephrin-Bs). Eph receptors can be grouped into two
lost in vab-1 mosaic animals. The origin of the main head epidermal subclasses: the EphA receptors, which bind ephrin-A
syncytia (hyp4, hyp5, hyp6, and anterior of hyp7) is shown. Black ligands, and the EphB receptors, which bind trans-
circle, strong head morphogenetic defect; gray circle, moderate or
membrane ephrin-B ligands (Gale et al., 1996). VAB-1 isweak morphogenetic defect (Figures 6C and 6D). Open circle, wild-
equally similar in sequence to EphA and EphB receptorstype morphology. (B) Wild-type (N2) head morphology. (C and D)
and thusmay be similar to a common ancestor of the twoVab phenotypes resulting from losses of vab-1 function outside of
the epidermis. (C) Head region of typical ABprp mosaic, L4 stage, vertebrate subclasses. We have also identified ephrin-
displaying moderate Vab phenotype. (D) Typical ABplp mosaic dis- related genes in the C. elegans genomic sequence
playing moderate Vab phenotype. Bar, 20 mm. (A. D. C. and S. E. G., unpublished data), indicating that
potential ligands for VAB-1 exist in C. elegans and thus
cells, neuronal cells, and neuronal support cells (Figure that ephrin signaling pathways may be conserved be-
5A). In general, only early losses (in AB or ABp) of vab-1 tween nematodes and vertebrates.
function caused strong morphogenetic defects, sug-
gesting that vab-1 functions in many AB-derived cells.
VAB-1 Might Participate in ForwardFive losses of vab-1 function outside the AB lineage did
and Reverse Signalingnot cause morphological defects (Figure 5A).
Vertebrate Ephreceptors may participate in bothkinase-The early focus of vab-1 function in the AB lineage
dependent ªforwardº signaling and in kinase-indepen-might reflect a requirement for vab-1 in many epidermal
dent ªreverseº signaling. For example, deletion of thecells, in many nonepidermal cells, or both. To determine
kinase domain of murine Nuk/EphB2 did not affect itswhether vab-1 was required in epidermal or nonepider-
function in axonal guidance in the anterior commissuremal cells, we identified mosaics in which vab-1 had been
(Henkemeyer et al., 1996). EphB2 is not expressed onlost from precursors at the AB8 stage or later; at this
anterior commissure axons but on substrate cells overstage three precursors (ABarp, ABpra, and Abpla) gener-
which the axons navigate. A transmembrane ligand forate the headepidermal cells hyp4,hyp5, and hyp6.Three
EphB2, ephrin-B1/LERK-2, is expressed on anteriorof 18 mosaic animals in which vab-1 was lost in epider-
commissure axons, and EphB2 binding to ephrin-Bs canmal precursors (in ABpla, ABplaa, Abpra, or ABpraa)
induce phosphorylation of tyrosines on the intracellulardisplayed Vab phenotypes. By contrast, 12 of 14 mosaic
domain of the ephrin-B, thus potentially activating aanimals in which vab-1 had been lost only from nonepi-
signaling cascade in the ligand-expressing cell (Hollanddermal precursors (ABplp, ABplpa, ABprp, and ABprpa)
et al., 1996; BruÈ ckner et al., 1997).displayed Vab phenotypes (Figures5B and 5C). Our data
VAB-1 likely has some forward signaling functions,clearly show that losses of vab-1 function in neuronal
because missense alterations of conserved residues inlineages cause non±cell-autonomous defects in epider-
the kinase domain cause partial reduction in vab-1 func-mal morphogenesis, consistent with our data showing
tion. However, none of the VAB-1 kinase alleles causesthat VAB-1::GFP is mostly expressed in neurons from
complete loss of vab-1 function. It is possible that thethe ventral enclosure stage onward. However, we can-
weak phenotype of these mutants is due to residualnot exclude the possibility that vab-1 has additional cell-
kinase activity. However, the kinase subdomains de-autonomous roles in the epidermal cells.
leted in e118 mutants contain residues essential for
catalytic activity (Yaciuk and Shalloway, 1986); also, le-Discussion
sions equivalent to those of vab-1(e2) and vab-1(e116)
were found in the null alleles sy7 and sy5 of the C.We show here that vab-1, which functions in epidermal
morphogenesis in C. elegans, encodes an Eph receptor elegans let-23 RPTK, indicating that such mutations
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that normally provide a permissive substrate for epider-
mal cell movements. Mispositioned neuronal precursors
resulting from the gastrulation cleft defects seen in
vab-1 mutant embryos could interfere with normal epi-
dermal migration and likely contribute to the epidermal
defects seen in severely mutant vab-1 animals (class
I-III). However, we often observe defects in enclosure
in the absence of obvious defects in cleft closure (class
IV phenotype). Thus, defects in epidermal enclosure do
not appear to be solely due to defects in neuroblast
movements following gastrulation.
In the ªreverse signalº model (Figure 6B), neurons
signal directly to epidermal cells, potentially providing
Figure 6. Two Models for the Function of VAB-1 in Epidermal Mor- cues for their migration. As discussed above, VAB-1
phogenesis
could participatedirectly in such reverse signaling, anal-
See discussion for details.
ogous to that observed for vertebrate Eph receptors.
Alternatively, VAB-1 could receive a signal from epider-
mal cells and thereby activate a second signaling path-
cause complete loss of activity of the LET-23 kinase way in the reverse direction. Two observations further
(Aroian et al., 1994). Thus, the VAB-1 kinase domain suggest that VAB-1±expressing cells might provide an
mutations should abolish kinase activity. inhibitory signal to epidermal cells. First, in wild-type
An alternative explanation for the weak phenotypes embryos the leading cells migrate posteriorly and adja-
of vab-1 kinase mutants is that VAB-1, in addition to cently to VAB-1±expressing cells (Figures 4B±4E). Sec-
kinase-dependent forward signaling functions, has ki- ond, in some vab-1 mutant embryos the leading cells
nase-independent reverse signaling functions. Such migrate anteriorly to their normal positions, possibly a
result of a lack of anterior repulsive cues. Identificationfunctions presumably require the VAB-1 extracellular
and localization of ligands for VAB-1 is necessary todomain, possibly interacting with ephrin ligands, and
distinguish between these two models for VAB-1.would explain why only mutations disrupting the VAB-1
Our genetic analysis of vab-1 has shown that the nullextracellular domain would cause null phenotypes. As
phenotype of vab-1 is a variable defect in epidermaldiscussed below, VAB-1 reverse signaling could ac-
morphogenesis. As a small percentage of vab-1 nullcount for the nonautonomous role of vab-1 in epidermal
mutants develop into apparently normal adults, vab-1morphogenesis. As both weak and strong vab-1 alleles
function is not essential. vab-1 signaling may be partlyappear to cause similar ranges of phenotypes with dif-
redundant with other signaling pathways, as found forferent penetrances, the kinase-dependent and kinase-
some vertebrate Eph receptors (Orioli et al., 1996), al-independent functions of vab-1 may be required for re-
thoughno additional Eph receptorshave yetbeen identi-lated aspects of morphogenesis.
fied in the C. elegans genomic sequence.
The Role of VAB-1 in Signaling from Neurons to Eph Signaling in Vertebrate Morphogenesis
Epidermis during Epidermal Morphogenesis Signaling via Eph receptors and ligands has been im-
vab-1 mutants are defective in the movements of neuro- plicated in axon guidance and topographic mapping
blasts that close the ventral gastrulation cleft and the (Cheng et al., 1995; Gao et al., 1996; Henkemeyer et
movements of the epidermal leading cells that initiate al., 1996; Nakamoto et al., 1996). Ephrin signaling can
epidermal enclosure. Unexpectedly, vab-1 is not ex- function as a repulsive cue for axon guidanceby promot-
pressed in the epidermal leading cells but in neurons ing growth cone collapse (Drescher et al., 1995). Ephrin
underlying or adjacent to the leading cells. In addition, signaling has also been shown to promote axon fascicu-
our mosaic analysis has shown that loss of vab-1 func- lation (Winslow et al., 1995), formation of rhombomere
tion in nonepidermal precursors causes epidermal mor- boundaries (Xu et al., 1995), and to inhibit cell±cell adhe-
phogenetic defects. Our results suggest that a major sion (Winning et al., 1996). A common feature of Eph-
function of vab-1 is in neuronal cells and that the epider- mediated signaling is thus the modulation of cell shape
mal morphogenesis defects of vab-1 mutants in part and cell adhesion, processes critical to epithelial mor-
result from defects in neuronal cells. Thus, despite its phogenesis.
similarity to receptors, VAB-1 acts in signaling rather The expression patterns of many vertebrate Eph re-
than responding cells. ceptors suggest they may be functioning in epithelial
Our observations raise two questions: what signals morphogenesis. For example, EphB2/Nuk is expressed
do underlying neurons provide to migrating epidermal in midline epithelial cells of the palatal shelves as they
cells, and does VAB-1 function directly in such neuronal- begin to fuse in themidline. Mice lacking both the EphB2
to-epidermal signaling? We propose two models for this and EphB3/Sek4 receptors have cleft palates as a result
process (Figure 6). These two models are not mutually of failure in closure of the secondary palate, possibly
exclusive, and the phenotypes of vab-1 mutants suggest due to defective epithelial morphogenesis (Orioli et al.,
that both models might apply. In the ªsteric hindranceº 1996). Many other Eph receptors are expressed in epi-
model (Figure 6A), VAB-1 signaling only occurs between thelial or endothelial organs undergoing morphogene-
neuronal precursors, and the epidermal defects in vab-1 sis, such as lung, heart (Ruiz et al., 1994), or in migrat-
ing cells (BraÈ ndli and Kirschner, 1995). Determining themutants are a result of defects in neuronal precursors
Eph Receptor in C. elegans Morphogenesis
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(Rol) phenotype (Mello et al., 1991). Transgenic lines carrying pRF4roles of vertebrate Eph receptors in these processes
and M03A1 in extrachromosomal arrays were established andmay be complicated by redundancy between members
scored for rescue of the Vab-1 phenotypes. Five of six lines showedof this gene family; for example, EphA2/Eck is specifi-
rescue of the vab-1 embryonic lethality and head morphology de-
cally expressed during mouse gastrulation (Ruiz and fects (2.8% of Rols were Vab in rescued lines), compared with 0/2
Robertson, 1994), yet Eck mutant mice show no discern- control lines bearing pRF4 alone (86.5% of Rols were Vab).
ible phenotype (Chen et al., 1996). vab-1 may provide a
Analysis of vab-1 cDNA Sequencerelatively simple model for understanding the functions
cDNAs from the vab-1 locus had been isolated in a genome-wideof Eph receptors in these aspects of vertebrate morpho-
EST project (Y. Kohara, personal communication). The longest cDNAgenesis.
clone, yk18c8, contains a 2992 bp insert that we sequenced, corre-
sponding to bases 700±3962 of the composite vab-1 cDNA. We
Experimental Procedures determined the 59 end (bases 1±699) of the vab-1 transcript in RT-
PCR experiments; RT-PCR using the SL1 trans-spliced leader se-
Genetic Analysis of vab-1 quence as upstream primer (Krause and Hirsh, 1987) generated
C. elegans strains were cultured using standard methods (Brenner, products, indicating that the vab-1 message is trans-spliced to SL1.
1974). Mutations used were as follows: LGI, unc-29(e1072); LG II, lin- The vab-1 cDNA sequence is 3962 bp in length, consistent with the
31(n301), hlh-1(cc450), dpy-25(e817sd), and tra-2(q122dm) (Schedl 4 kb band observed on Northern blots (data not shown), including
and Kimble, 1988); LGIII, ncl-1(e1865); and LGX, lin-15(n765ts). Re- an SL1 trans-spliced leader, an 89 bp 59 UTR, a 3354 bp open
arrangements used were ccDf4II and maDf4II. Mutations are de- reading frame, and a 458 bp 39 UTR. No evidence was found for
scribed in Hodgkin (1997) or in references above. alternative vab-1 transcripts either by Northern blot or RT-PCR ex-
vab-1 alleles were isolated in general screens for visible mutations periments.
by S. Brenner (e2, e116, e118, e200, e699, e721, e856, and e1059),
J. Lewis (e1029), J. Hodgkin (e1063), A. Fire (e2027), E. Lambie (dx14,
Determination of Mutant DNA Sequences
dx31), M. Zhen (ju8), D. Ostertag (ju22, ju63), and D. Greenstein (tn2).
We determined thesequences of genomic DNAs from vab-1 mutants
All alleles were EMS-induced except dx14 and dx31, which were
as described previously (Chisholm and Horvitz, 1995). vab-1 exons
UV-induced, and e2027, which arose spontaneously. All mutations
and splice sites were amplified from all vab-1 mutants (except the
fail to complement vab-1(e2). Map data showing that vab-1 lies
deletion alleles dx14, dx31, e118, and e2027) and PCR products
close to the right of hlh-1 are available from the Caenorhabditis
sequenced using 33P labeled primers and the fmol kit (Promega). All
Genetics Center.
mutations were confirmed on both strands and in independent
PCRs. The molecular lesions of two vab-1 mutations (e721 and
Phenotypic Analysis e1029) have not yet been found. Sequences of primers used are
We determined the penetrance of vab-1 mutant phenotypes by pick- available upon request.
ing L4 animals from homozygous strains to separate plates, allowing The vab-1 alleles dx14 and dx31 result from rearrangements,
them to self, and transferring them every 24 hr. Eggs unhatched based on Southern blot analysis of mutant genomic DNA (data not
after 24 hr were scored as embryonic arrest. Larvae that failed to
shown). dx31 causes a deletion of at least 7 kb, removing exons
develop into adults after 48 hr were scored as larval arrest. Any
1-4. dx14 appears to be a complex rearrangement, resulting in an
morphological abnormality of the head region was scored as abnor-
approximately 2 kb deletion that deletes exon 4 and the first half of
mal. At least 500 individuals were scored for each genotype.
exon 5.
We determined the stages at which vab-1 embryos arrest by fol-
lowing the development of vab-1 embryos using Nomarski micros-
vab-1::GFP Reporter Constructscopy. Embryos were followed from comma stage or before until
The VAB-1::GFP construct pCZ55 used for expression studies is aeither development arrested or the embryo hatched. To generate
translational fusion of GFP to a vab-1 minigene and contains 4.2 kbembryos heterozygous for vab-1 alleles and the deficiency ccDf4,
of genomic sequence 59 to the vab-1 start codon, exons 1-5 (to thewe mated males carrying the dominant feminizing mutation tra-
SmaI site in exon 5) as genomic DNA, exons 6-10 as cDNA, GFP2(q122) with ccDf4/dpy-25 hermaphrodites; non-Dpy cross progeny
inserted in frame at the XhoI site near the VAB-1 N terminus, theare ccDf4/tra-2 females. These females were mated with vab-1/1
vab-1 39 UTR, and 0.4 kb of genomic DNA 39 to the polyadenylationmales. One quarter of the F1 animals from this cross will be of
site.genotype vab-1/ccDf4.
Transgenic lines were generated by transformation of vab-To generate animals transheterozygous for deficiencies that
1(e2027); lin-15 animals with pCZ55 and the lin-15 rescuing plasmiduncover vab-1, tra-2(q122) males were mated with ccDf4/dpy-25
pLin-15EK (Clark et al., 1994); four independent chromosomal inte-hermaphrodites and maDf4/dpy-25 hermaphrodites in separate
grants (juIs24, juIs31, juIs32, and juIs33) were identified followingcrosses. Non-Dpy female cross progeny (genotype ccDf4/q122)
X-ray mutagenesis. Expression was analyzed in the strain CZ723 offrom the first cross were mated with non-Dpy male cross progeny
genotype vab-1(e2027); lin-15(n765); juIs24(vab-1::GFP; lin-15[1])(genotype maDf4/q122) from the second cross. One quarter of the
by staining fixed transgenic animals with anti-GFP antibodies. Em-progeny of this cross were ccDf4/maDf4 heterozygotes.
bryos were fixed in 1% paraformaldehyde and incubated with anti-
GFP polyclonal antisera (Clontech) at 1:100 to 1:500 dilution andAnalysis of Cell Movements by Time-Lapse
with MH27 monoclonal (1:1500). Staining was visualized with fluo-Nomarski Microscopy
rescently conjugated secondary antibodies using a confocal micro-Four-dimensional microscopy was used to record and follow cell
scope. VAB-1::GFP staining patterns in all four lines were indistin-movements as described (Williams-Masson et al., 1997). To gener-
guishable.ate the movies analyzed, 30 focal planes 0.5 mm apart wererecorded
every 60 s. A total of 58 vab-1(e2027) embryos were recorded from
Analysis of vab-1 Genetic Mosaicsearly gastrulation until they had reached a terminal phenotype. We
We used two approaches to identify vab-1 mosaic animals. In bothfound that some vab-1 embryos develop more slowly than wild-
approaches we generated transgenic arrays bearing wild-type cop-type embryos following gastrulation and morphogenesis. Wild-type
ies of vab-1 and cell-autonomous marker genes (Herman, 1995).embryos took 320 min to develop from the eight-cell stage to the
First, we generated strains of genotype unc-29; vab-1; juEx(unc-beginning of elongation. vab-1 embryos took up to 55 min longer
29[1] vab-1[1] sur-5-GFP) by transformation of unc-29; vab-1to develop to this stage, with the developmental delay correlating
worms with cosmid DNAs C45G10 (unc-29[1] [Miller et al., 1996]),with the severity of the morphogenetic defects.
M03A1 (vab-1[1]) and the sur-5-GFP plasmid pTG96.1. sur-5-GFP
is expressed in most somatic cell nuclei (T. Gu and M. Han, personalTransformation Rescue of vab-1
communication) and is a cell-autonomous marker for the array; unc-vab-1(e2027) animals were injected with cosmid M03A1 (15 mg/ml)
and the plasmid pRF4 (50 mg/ml), which confers a dominant Roller 29(1) is required in body muscles (derived from P1) (Miller et al.,
Cell
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1996). From such strains, three Unc non-Vab mosaics were identified Chen, J., Nachabah, A., Scherer, C.P.G., Reith, A., Bronson, R., and
Ruley, H.E. (1996). Germ-line inactivation of the murine Eck receptorand found to have lost the array in P1. We then screened for Vab
tyrosine kinase by gene trap retroviral insertion. Oncogene 12,non-Unc animals (putative mosaics with losses in AB). Twenty-three
979±988.of such animals were found that had patterns of sur-5-GFP interpret-
able as resulting from losses of the array within AB. Cheng, H.-J., Nakamoto, M., Bergemann, A.D., and Flanagan, J.G.
We used the cell-autonomous marker ncl-1 (Hedgecock and Her- (1995). Complementary gradients inexpression and binding of ELF-1
man, 1995) in additional mosaic analysis experiments. We generated and Mek4 in development of the topographic retinotectal projection
the strain CZ712 vab-1; ncl-1; juEx39(vab-1[1] ncl-1[1] rol-6[dm]) map. Cell 82, 371±381.
by transformation with cosmids containing the wild-type copies of Chisholm, A.D., and Horvitz, H.R. (1995). Patterning of the head
vab-1 (M03A1), ncl-1(C33D3 [Miller et al., 1996]) and pRF4. Expres- region of Caenorhabditis elegans by the Pax-6 family membervab-3.
sion of rol-6(dm) in cells contributing to the epidermal syncytium Nature 377, 52±55.
hyp7 confers a Rol phenotype. Transgenic animals are thus Rol
Clark, S.G., Chisholm, A.D., and Horvitz, H.R. (1993). Control of cellnon-Vab non-Ncl. We screened CZ712 Rols for rare Rol Vab animals,
fates in the central body region of C. elegans by the homeobox
predicted to be mosaics in which the array had been lost from a
gene lin-39. Cell 74, 43±55.
subset of hyp7 precursors. We found 15 mosaics with patterns of
Clark, S.G., Lu, X., and Horvitz, H.R. (1994). The CaenorhabditisNcl cells resulting from single losses of the array. Ncl cannot be
elegans locus lin-15, a negative regulator of a tyrosine kinase signal-scored in syncytial nuclei unless all precursors of the syncytium
ing pathway, encodes two different proteins. Genetics 137, 987±997.have lost the array, so we assessed the loss point by scoring identifi-
Connor, R.J., and Pasquale, E.B. (1995). Genomic organization andable cell nuclei, as described (Clark et al., 1993).
alternatively processed forms of Cek5, a receptor protein-tyrosineOf the 15 Rol Vab mosaic animals, 4 had losses in the nonepider-
kinase of the Eph subfamily. Oncogene 11, 2429±2438.mal precursors ABprp and ABplp. As these mosaics had been se-
lected on the basis of their Vab phenotype, it was possible that they Costa, M., Wilson, E.T., and Wieschaus, E. (1994). A putative cell
were rare double loss mosaics in which the Vab phenotype was due signal encoded by the folded gastrulation gene coordinates cell
to loss of the array in epidermal cells (which we could not directly shape changes during Drosophila gastrulation. Cell 76, 1075±1089.
score), rather than the observed loss in nonepidermal precursors. Drescher, U., Kremoser, C., Handwerker, C., LoÈ schinger, J., Noda,
To address this caveat we screened CZ712 Rols directly for mosa- M., and Bonhoeffer, F. (1995). In vitro guidance of retinal ganglion
icism of the Ncl marker. From 800 Rols screened we identified 42 cell axons by RAGS, a 25 kDa tectal protein related to ligands for
animals with mosaic Ncl expression. Of these 42 mosaics, 8 had the eph receptor tyrosine kinases. Cell 82, 359±370.
lost the array in nonepidermal precursors, of which 6 were Vab, and Eph Nomenclature Committee (1997). Unified nomenclature for Eph
13 had lost the array in head epidermal precursors, of which 1 was family receptors and their ligands, the ephrins. Cell 90, 403±404.
Vab. Thus, loss of vab-1 function in nonepidermal precursors can
Fox, G.M., Holst, P.L., Chute, H.T., Lindberg, R.A., Janssen, A.M.,frequently cause Vab phenotypes.
Basu, R., and Welcher, A.A. (1995). cDNA cloning and tissue distribu-
tion of five human EPH-like receptor protein-tyrosine kinases. Onco-
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